International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, published by the NATL INST SCIENCE COMMUNICATION-NISCAIR, stands as a significant platform for the dissemination of original research in the fields of biochemistry, genetics, and molecular biology, particularly within the context of Indian scientific advancements. With its ISSN 0019-5189 and E-ISSN 0975-1009, the journal has been an essential resource since its inception in 1965, although coverage in prominent databases like Scopus was discontinued in 2018. The journal ranks in the 57th percentile for Biotechnology, as well as in the 27th and 25th percentiles for Molecular Biology and Cell Biology respectively, underscoring its impact and relevance. While currently not an Open Access journal, it continues to provide valuable insights and contributions from researchers and professionals in the growing field of experimental biology. The esteemed contributions published in this journal enhance our understanding of biological processes and foster the development of innovative solutions to contemporary challenges in health and environmental science.

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.

Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

The Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale is a premier peer-reviewed journal published by PAGEPRESS PUBL, focusing on a diverse array of topics within the broad field of biological research. Established as an Open Access journal since 2009, it facilitates the dissemination of scientific knowledge across the globe, enhancing visibility and accessibility for researchers, professionals, and students alike. With an ISSN of 1826-8838 and E-ISSN 2284-0230, this journal serves as a platform for innovative studies in Biochemistry, Genetics, and Molecular Biology, with a growing emphasis on Plant Science. Although currently categorized in the Q4 quartile for various sub-disciplines, the journal is dedicated to fostering interdisciplinary collaboration and advancing research quality. The latest Scopus rankings indicate a burgeoning presence in the academic community, positioning itself at significant ranks within the fields it covers. With publication coverage extending from 2011 to 2024, the journal aims to push the frontiers of biological research while adapting to the evolving demands of the scientific community.

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.